Axsome: Axsome's latest win comes in ADHD, Opthea seeks path after AMD miss, and more: Clinical Report
MAR 25, 2025 | 5:53 PM PDT | BIOCENTURY | PRODUCT DEVELOPMENTAXSOME'S LATEST WIN COMES IN ADHD, OPTHEA SEEKS PATH AFTER AMD MISS, AND MORE: CLINICAL REPORTBY Plus: https://www.biocentury.com/article/655443/axsome-s-latest-win-comes-in-adhd-opthea-seeks-path-after-amd-miss-and-more-clinical-report© 2025 BioCentury Inc. All Rights Reserved
Read full article »
Axsome is a New York-based biopharmaceutical company that researches and develops novel therapies for the treatment of central nervous system disorders.
Read more